Companies: 10,795·Total market cap: $144.5T
Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc.

ELOXOTCHealthcare● Active
$6.20
$-2.80(-31.11%)
Market Cap$46952426
P/E Ratio
52W High$10
52W Low$0.00011
Overview

Eloxx Pharmaceuticals, Inc. (ELOX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ELOX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-41.80elox eps ttm · elox earnings per shareEarnings history
PE Ratio (TTM)elox pe ratio ttm · elox price to earningsPE Ratio deep dive
Revenue (TTM)0.00elox revenue ttm · elox annual revenueFull revenue history
Dividend YieldNo Dividenddoes elox pay dividends · elox dividend yieldDividend history
Shares Outstanding1.1Melox shares outstanding · elox floatShares outstanding history
Next EarningsAug 10, 2026Est.elox earnings date · elox next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202120222025
eloxx pharmaceuticals, inc. revenue · elox revenue 2025
FY 2025Net Income-$6.0M▲ +83.38% YoY
202120222025
eloxx pharmaceuticals, inc. net income · elox profit 2025
FY 2025EPS$-5.39▲ +97.06% YoY
202120222025
elox eps · eloxx pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$13.4MEPS: $-41.80View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis elox a buy · elox analyst rating
Strong Buy
0
Buy
8
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$6.20Current
$Avg Target
$High
elox price target · elox 12 month forecast

Total: 11 · Buy rate: 72.7%

Stock Performance

Full History
1D-31.11%
1W-19.06%
1M+4665.56%
3M+6199900.19%
YTD+6199900.00%
1Y+6199900.19%
5Y-91.48%

About Eloxx Pharmaceuticals, Inc.

CEOSumit Aggarwal
IPO DateApr 26, 1999
Employees18
CountryUS

Eloxx Pharmaceuticals, Inc. Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Its primary objective is to address rare and ultra-ra…

what is eloxx pharmaceuticals, inc. · elox stock overview · eloxx pharmaceuticals, inc. company profile · who is eloxx pharmaceuticals, inc. ceo · elox OTC · eloxx pharmaceuticals, inc. headquarters · eloxx pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Eloxx Pharmaceuticals, Inc. (ELOX) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 26, 1999. As of the latest trading session, ELOX stock price is $6.20, with a market capitalization of $47.0M. The stock has returned +6199900.19% over the past 12 months and +6199900.00% year-to-date.

According to 11 Wall Street analysts, the consensus rating for Eloxx Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Eloxx Pharmaceuticals, Inc. reported revenue of — and net income of -$6.0M. For detailed data — including Eloxx Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Eloxx Pharmaceuticals, Inc. (ELOX) stock price is $6.20. The stock is traded on OTC under the ticker symbol ELOX. The 52-week range is $0.00 – $10.00.

ELOX stock priceELOX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice